GLIMEPIRIDE | A202759 | AUROBINDO PHARMA LTD
Highest NADAC/Unit
$0.0464
per ea
Lowest NADAC/Unit
$0.0249
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 16571077501GLIMEPIRIDE 4 MG TABLET | $0.0464 | EA | Generic | — | 2026-10-21 |
| 16571077550GLIMEPIRIDE 4 MG TABLET | $0.0464 | EA | Generic | — | 2026-10-21 |
| 16571077401GLIMEPIRIDE 2 MG TABLET | $0.0375 | EA | Generic | — | 2026-10-21 |
| 16571077450GLIMEPIRIDE 2 MG TABLET | $0.0375 | EA | Generic | — | 2026-10-21 |
| 16571077301GLIMEPIRIDE 1 MG TABLET | $0.0249 | EA | Generic | — | 2026-10-21 |
| 16571077350GLIMEPIRIDE 1 MG TABLET | $0.0249 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.